progesterone micronized

Adult Dosing .

Dosage forms:  CAP: 100 mg, 200 mg

amenorrhea, secondary

[400 mg PO qhs x10 days]

Info: consider D/C treatment 4-6wk before surgery if VTE risk

endometrial hyperplasia prevention, postmenopausal

[200 mg PO qhs x12 days q4wk]

Info: for patients with intact uterus receiving continuous estrogen; consider D/C treatment >4-6wk before surgery if VTE risk

hypoestrogenism (off-label)

[100-200 mg PO qd x10-12 days q4wk]

Info: for patients with intact uterus receiving continuous estrogen

renal dosing

[see below]

renal impairment: not defined, caution advised

HD/PD: not defined, caution advised

hepatic dosing

[see below]

hepatic impairment: contraindicated

Peds Dosing .

Dosage forms:  CAP: 100 mg, 200 mg

puberty induction, female (off-label)

[100-200 mg PO qd x10-12 days q4wk]

Start: after breakthrough bleeding occurs or with at least 2 years of estrogen treatment if intact uterus

renal dosing

[not defined]

renal impairment: consider adult renal dosing for guidance

HD/PD: consider adult renal dosing for guidance

hepatic dosing

[not defined]

hepatic impairment: consider adult hepatic dosing for guidance